The global Automated Breast Ultrasound (ABUS) Market is growing rapidly and is expected to reach USD 1,146.8 million by 2032 with a revenue CAGR of 7.8% during the forecast period. The primary drivers of this growth are the increasing prevalence of breast cancer, rising public awareness about early detection, and the need for accurate screening techniques.
The accuracy and dependability of ABUS systems are being improved by the development of high-resolution ultrasound imaging and 3D/4D imaging capabilities, which is creating high demand for these systems.
Get a free sample PDF of the report, visit @
https://www.reportsanddata.com/download-free-sample/6320
Revenue growth of the market is driven by rising adoption of ABUS systems in healthcare institutions, and government programs to target breast cancer identification and screening are also boosting market income. However, the high cost and narrow reimbursement coverage of ABUS systems could be a major factor that restrains the growth of the market. ABUS is being used increasingly in hospitals, diagnostic centers, and other healthcare facilities to increase breast cancer screening and diagnosis rates.
Key players in the Automated Breast Ultrasound (ABUS) Market:
- General Electric Company
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- Hologic, Inc.
- SonoCine, Inc.
- Hitachi, Ltd.
- Fujifilm Holdings Corporation
- Volpara Health Technologies Limited
- Breast Imaging Technologies (BIT)
- iVu Imaging Corporation
The Asia Pacific market dominates the market with the highest share, owing to the growing awareness among women in this region and the rising demand for advanced technologies. According to the American Cancer Society, breast cancer is the most common type of cancer among women in the US, with an estimated 252,710 new cases expected in 2020. Early diagnosis is key to effective treatment of breast cancer, and ABUS can detect lesions that may not be visible on a mammogram or ultrasound.
To know more about the latest insights of the report, visit @
https://www.reportsanddata.com/request-latest-insight/6320
Government regulations play a critical role in the sale, marketing, and use of ABUS systems in different countries. The US FDA, European Commission, Canadian Medical Devices Regulations, Australian Therapeutic Goods Act, and Japanese Pharmaceutical and Medical Device Act regulate the sale, use, and marketing of ABUS systems in their respective countries.
Based on product, the global automated breast ultrasound market is segmented into automated breast ultrasound systems and Automated Breast Volume Scanner (ABVS). The automated breast ultrasound system segment accounted for the largest revenue share in 2022. The introduction of automated breast ultrasonography devices is being driven by the rising prevalence of breast cancer and the need for early detection. Women with dense breast tissue can use ABUS, a specific form of ultrasound technology, for breast cancer screening. ABUS provides a 3D image of the breast tissue, which differs from standard mammography and may aid in the early diagnosis of breast cancer. Moreover, ABUS is a non-invasive, radiation-free alternative to mammography.
In conclusion, the ABUS market is growing rapidly due to the increasing prevalence of breast cancer, rising public awareness about early detection, and the need for accurate screening techniques. ABUS systems are being increasingly used in healthcare institutions, and government programs to target breast cancer identification and screening are boosting market income. However, the high cost and narrow reimbursement coverage of ABUS systems could restrain the growth of the market.
Request a customized copy of the report @
https://www.reportsanddata.com/request-customization-form/6320
Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Browse for more report:
